Literature DB >> 17479931

Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.

Miriam Wiese-Posselt1, Dagmar Heuck, Andreas Draeger, Martin Mielke, Wolfgang Witte, Andrea Ammon, Osamah Hamouda.   

Abstract

BACKGROUND: Skin infections due to Staphylococcus aureus have recently become a public concern, mainly because of emerging resistance against widely used antibiotics and specific virulence determinants. Strains harboring the lukS-lukF gene (which codes for Panton-Valentine leukocidin) are frequently associated with severe furunculosis. Generally applicable strategies for the control of community outbreaks of furunculosis have not been defined.
METHODS: We report the investigation and successful termination of an outbreak of furunculosis due to lukS-lukF-positive S. aureus in a German village (n=144). Nasal swab specimens were obtained from village residents. A retrospective cohort study was conducted. Nasally colonized persons, persons who had current furuncles or who had experienced relapsing furuncles since 2002, and their family members underwent stringent decolonization measures using mupirocin nasal ointment and disinfecting wash solution. Multiple nasal swab specimens were obtained to monitor the long-term outcome of decolonization measures.
RESULTS: From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding. Of 140 participants tested, 51 (36%) were found to be nasally colonized with S. aureus. In 9 participants, the strain was positive for lukS-lukF. No methicillin resistance was detected. Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9). Passive surveillance implemented in January 2005 did not detect any case of lukS-lukF-positive, S. aureus-associated furuncles in this village.
CONCLUSION: This report describes a successful strategy for terminating the transmission of epidemic strains of S. aureus among a nonhospitalized population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479931     DOI: 10.1086/517503

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Community acquired MRSA in Europe.

Authors:  Tristan Ferry; Jerome Etienne
Journal:  BMJ       Date:  2007-10-23

2.  Long-term persistence of a multi-resistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) clone at a university hospital in southeast Sweden, without further transmission within the region.

Authors:  M Lindqvist; B Isaksson; J Swanberg; R Skov; A R Larsen; J Larsen; A Petersen; A Hällgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-27       Impact factor: 3.267

3.  Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus.

Authors:  Helena Masiuk; Katarzyna Kopron; Dorothee Grumann; Christiane Goerke; Julia Kolata; Joanna Jursa-Kulesza; Stefania Giedrys-Kalemba; Barbara M Bröker; Silva Holtfreter
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

4.  Patients with Panton-Valentine leukocidin positive Staphylococcus aureus infections run an increased risk of longer hospitalisation.

Authors:  L Cupane; N Pugacova; D Berzina; V Cauce; D Gardovska; E Miklaševics
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-28

5.  Treatment of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Kyle J Popovich; Bala Hota; Robert A Weinstein
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

Review 6.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

7.  Treatment of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Kyle J Popovich; Bala Hota; Robert A Weinstein
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

8.  Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria.

Authors:  Adebayo O Shittu; Kenneth Okon; Solayide Adesida; Omotayo Oyedara; Wolfgang Witte; Birgit Strommenger; Franziska Layer; Ulrich Nübel
Journal:  BMC Microbiol       Date:  2011-05-05       Impact factor: 3.605

9.  Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.

Authors:  Marc-Nicolas Rentinck; Renate Krüger; Pia-Alice Hoppe; Daniel Humme; Michaela Niebank; Anna Pokrywka; Miriam Stegemann; Axel Kola; Leif Gunnar Hanitsch; Rasmus Leistner
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

10.  Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report.

Authors:  Joerg C Schefold; Fabrizio Esposito; Christian Storm; Dagmar Heuck; Anne Krüger; Achim Jörres; Wolfgang Witte; Dietrich Hasper
Journal:  J Med Case Rep       Date:  2007-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.